Ependymoma, Recurrent Recruiting Phase 1 Trials for Azacitidine (DB00928)

Also known as: Ependymoma Recurrent / Recurrent Ependymoma

IndicationStatusPhase
DBCOND0106575 (Ependymoma, Recurrent)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03572530Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Patients With Recurrent Posterior Fossa EpendymomaTreatment